Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety

Background: Chronic migraine is a common, highly disabling, underdiagnosed and undertreated entity of migraine. It affects 0.9%–2.2% of the general adult population. The present paper overviews the preclinical and clinical data regarding the therapeutic effect of onabotulinumtoxinA in chronic migrai...

Descripción completa

Detalles Bibliográficos
Autores principales: Szok, Délia, Csáti, Anett, Vécsei, László, Tajti, János
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516935/
https://www.ncbi.nlm.nih.gov/pubmed/26193319
http://dx.doi.org/10.3390/toxins7072659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516935/
https://www.ncbi.nlm.nih.gov/pubmed/26193319
http://dx.doi.org/10.3390/toxins7072659

Ejemplares similares